Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Conway

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Nature Medicine|July 11, 2006
VEGF inhibitors make bloodChristian Fischer, Peter Carmeliet, Edward M Conway
Current Drug Targets|December 31, 2011
CD248: reviewing its role in health and diseaseYanet Valdez, Margarida Maia, Edward M Conway
Nature Genetics|October 1, 2005
Lymph makes you fatMartin Schneider, Edward M Conway, Peter Carmeliet
Journal of Thrombosis and Haemostasis : JTH|August 8, 2020
Is the COVID-19 thrombotic catastrophe complement-connected?Edward M Conway, Edward L G Pryzdial
Current Opinion in Hematology|July 19, 2022
Complement contributions to COVID-19Edward M Conway, Edward L G Pryzdial
Critical Care Medicine|May 1, 2004
Novel functions of thrombomodulin in inflammationMarlies Van de Wouwer, Edward M Conway
Frontiers in Immunology|August 26, 2022
Coagulation and complement: Key innate defense participants in a seamless webEdward L G Pryzdial, Alexander Leatherdale, Edward M Conway
The Journal of Experimental Medicine|December 31, 2003
Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasisZheng Xing, Edward M Conway, Chulho Kang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2004
Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammationMarlies Van de Wouwer, Désiré Collen, Edward M Conway
Trends in Molecular Medicine|July 18, 2006
Another angiogenic gene linked to amyotrophic lateral sclerosisDiether Lambrechts, Peggy Lafuste, Peter Carmeliet, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Nature Medicine|July 11, 2006
VEGF inhibitors make bloodChristian Fischer, Peter Carmeliet, Edward M Conway
Current Drug Targets|December 31, 2011
CD248: reviewing its role in health and diseaseYanet Valdez, Margarida Maia, Edward M Conway
Nature Genetics|October 1, 2005
Lymph makes you fatMartin Schneider, Edward M Conway, Peter Carmeliet
Journal of Thrombosis and Haemostasis : JTH|August 8, 2020
Is the COVID-19 thrombotic catastrophe complement-connected?Edward M Conway, Edward L G Pryzdial
Current Opinion in Hematology|July 19, 2022
Complement contributions to COVID-19Edward M Conway, Edward L G Pryzdial
Critical Care Medicine|May 1, 2004
Novel functions of thrombomodulin in inflammationMarlies Van de Wouwer, Edward M Conway
Frontiers in Immunology|August 26, 2022
Coagulation and complement: Key innate defense participants in a seamless webEdward L G Pryzdial, Alexander Leatherdale, Edward M Conway
The Journal of Experimental Medicine|December 31, 2003
Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasisZheng Xing, Edward M Conway, Chulho Kang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2004
Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammationMarlies Van de Wouwer, Désiré Collen, Edward M Conway
Trends in Molecular Medicine|July 18, 2006
Another angiogenic gene linked to amyotrophic lateral sclerosisDiether Lambrechts, Peggy Lafuste, Peter Carmeliet, et al.
Pageof 11